CTT Pharmaceutical Holdings, Inc. has announced that its CEO, Ryan Khouri, acquired 3,700 shares of the company on October 6, 2026. This transaction is significant as it demonstrates Khouri's confidence in the company's prospects.
CTT Pharmaceutical Holdings, based in Tampa, Florida, operates in the pharmaceutical preparations industry, classified under SIC code 2834. The company trades on the OTC exchange under the ticker CTTH and is recognized as a smaller reporting company and an emerging growth company.
According to the recent SEC filing, Khouri's acquisition was made at a price of $0.055 per share. Following this transaction, he now holds a total of 9,433,656 shares in the company. The filing states, "Transaction Code: P" indicating a purchase of shares.
This acquisition may positively influence investor sentiment and could impact the company's stock performance as it reflects a commitment from leadership. Such insider transactions are often viewed as a sign of confidence in the company's direction, particularly in a competitive industry like pharmaceuticals.
The filing does not specify what actions will follow this transaction, leaving stakeholders to interpret the implications of Khouri's share acquisition.
Ryan Khouri, who holds the title of CEO at CTT Pharmaceutical Holdings, Inc., is also identified as both a director and an officer of the company, indicating his significant role in the organization's leadership structure. His recent share acquisition on October 6, 2026, is part of a broader trend where insiders demonstrate their confidence through personal investments in the company.
The SEC filing reveals that Khouri's transaction was executed at a price of $0.055 per share, and it is classified under transaction code 'P' for purchase. Following this acquisition, Khouri's total ownership in the company stands at 9,433,656 shares, reflecting a direct ownership nature.
CTT Pharmaceutical Holdings, Inc. is incorporated in Florida and operates from its business address located at 1646 W. Snow Ave, Suite 138, Tampa, FL 33606. The company has undergone several name changes in its history, previously known as Mindesta Inc., Industrial Minerals Inc., and PNW Capital Inc., with the most recent name change occurring on July 28, 2011.
The filing does not provide additional details regarding the company's future plans or strategic initiatives following Khouri's share purchase. Stakeholders may be left to speculate on how this acquisition aligns with the company's growth objectives and market positioning.